Xeris Biopharma Holdings, Inc.
XERS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$55 | -$62 | -$95 | -$123 |
| Dep. & Amort. | $13 | $13 | $13 | $2 |
| Deferred Tax | -$2 | -$1 | -$1 | -$1 |
| Stock-Based Comp. | $18 | $11 | $12 | $11 |
| Change in WC | -$9 | -$6 | -$35 | $12 |
| Other Non-Cash | -$2 | -$1 | $4 | $4 |
| Operating Cash Flow | -$37 | -$47 | -$103 | -$103 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$2 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $38 |
| Inv. Purchases | -$34 | -$44 | $0 | -$43 |
| Inv. Sales/Matur. | $40 | $40 | $35 | $35 |
| Other Inv. Act. | $0 | $0 | $0 | $5 |
| Investing Cash Flow | $5 | -$6 | $34 | $34 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $38 | $0 | $103 | $0 |
| Stock Issued | $0 | $1 | $30 | $27 |
| Stock Repurch. | -$4 | -$1 | -$0 | -$1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | -$1 | -$5 | $0 |
| Financing Cash Flow | $36 | -$2 | $127 | $27 |
| Forex Effect | $0 | $0 | -$4 | -$0 |
| Net Chg. in Cash | $4 | -$55 | $59 | $59 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $72 | $126 | $67 | $67 |
| End Cash | $76 | $72 | $126 | $126 |
| Free Cash Flow | -$38 | -$49 | -$103 | -$103 |